We previously showed hexameric TRAIL-receptor-agonist IZI1551 (IZI) [20, 21] to be superior in inducing apoptotic cell death in mutBRAF/MEK inhibition-sensitive and -resistant MM cells [22]. Here, MAP2K7 is linked to Miyoshi myopathy.